A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/27/2002	WO2002102390A1 Enhanced drug delivery in transdermal systems
12/27/2002	WO2002102385A1 Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
12/27/2002	WO2002102383A1 Aqueous cilostazol preparation for injection
12/27/2002	WO2002102377A1 Immune response modifiers for the treatment of periodontal disease
12/27/2002	WO2002102376A1 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT
12/27/2002	WO2002102358A1 Surface-doped plaster containing an active ingredient
12/27/2002	WO2002102357A1 A coated nicotine-containing chewing gum, manufacture and use thereof
12/27/2002	WO2002102356A2 Medicinal compositions comprising a melting core encapsulated in a hydroxypropylmethylcellulose film
12/27/2002	WO2002102355A2 Two part hard shell capsule made of poly (1,4-alpha-d-glucan)and starch
12/27/2002	WO2002102354A1 Lymphatic drug delivery system
12/27/2002	WO2002102353A1 Process for producing stable enteric sugar-coated tablet
12/27/2002	WO2002102352A1 Composition for the treatment of diseases which affect animals' hooves
12/27/2002	WO2002102331A2 Substrates utilizing shear responsive micropockets for storage and delivery of substances
12/27/2002	WO2002102311A2 Nanoparticles for treating targeted tissues and cells
12/27/2002	WO2002102309A2 Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders
12/27/2002	WO2002102305A2 Adjuvant composition for mucosal and injection delivered vaccines
12/27/2002	WO2002102304A2 Gum resin as a carrier for topical application of pharmacologically active agents
12/27/2002	WO2002102298A2 Process for the preparation of dispersions
12/27/2002	WO2002102163A1 Method and composition for enhancing sexual desire
12/27/2002	WO2002102129A2 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
12/27/2002	WO2002078668A3 Controlled morphologies in polymer drug for release of drugs
12/27/2002	WO2002076425A9 Manufacturing dissolvable dosage forms
12/27/2002	WO2002072072A3 Granules and granules coated with a masked taste
12/27/2002	WO2002072047A3 Cosmetic or pharmaceutical agent
12/27/2002	WO2002069888A3 Serotonin reuptake inhibitor formulations
12/27/2002	WO2002062335A3 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
12/27/2002	WO2002061036A3 Method of complexing a protein by the use of a dispersed system and proteins thereof
12/27/2002	WO2002060454A3 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
12/27/2002	WO2002058668A3 Artificial tear composition adapted to be used with contact lenses
12/27/2002	WO2002058666A3 Process for preparing non-hygroscopic sodium valproate composition
12/27/2002	WO2002056874A3 Lipid-based nitric oxide donors
12/27/2002	WO2002051400A3 Solid dosage forms of divalproex sodium
12/27/2002	WO2002049676A3 Compositions containing inclusion complexes
12/27/2002	WO2002047664A3 Microparticles with an improved release profile and method for the production thereof
12/27/2002	WO2002045746A3 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
12/27/2002	WO2002045701A3 Crystallization inhibition of drugs in transdermal drug delivery systems
12/27/2002	WO2002045695A3 Hydrostatic delivery system for controlled delivery of agent
12/27/2002	WO2002043510A3 Methods of stabilizing fruit-concentrate powders
12/27/2002	WO2002024165A3 Preparation of vitamin emulsions and concentrates thereof
12/27/2002	WO2002009702A3 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
12/27/2002	WO2002004623A3 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE
12/27/2002	WO2002002078A3 Improved liposomal camptothecins and uses thereof
12/27/2002	WO2001085141A9 β-GLUCANS ENCAPSULATED IN LIPOSOMES
12/27/2002	WO2001078706A9 Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
12/27/2002	WO2001030336A9 Pharmaceutical formulations comprising resveratrol and use thereof
12/27/2002	CA2456864A1 Adjuvant composition for mucosal and injection delivered vaccines
12/27/2002	CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002	CA2450847A1 Novel compositions
12/27/2002	CA2449754A1 Immune response modifiers for the treatment of periodontal disease
12/27/2002	CA2449288A1 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
12/27/2002	CA2448993A1 Process for the preparation of dispersions
12/27/2002	CA2448333A1 Substrates utilizing shear responsive micropockets for storage and delivery of substances
12/27/2002	CA2444356A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant
12/27/2002	CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use
12/26/2002	US20020198513 Ambulatory medical apparatus and method using a robust communication protocol
12/26/2002	US20020198486 Method of drug delivery to interstitial regions of the myocardium
12/26/2002	US20020198373 Particulate drug carriers
12/26/2002	US20020198315 Useful in the formulation of extended release pharmaceutical compositions
12/26/2002	US20020198266 Skin remedy, which allows gas transportation therethrough
12/26/2002	US20020198265 Antiseptic spermicidal composition and means for its application
12/26/2002	US20020198261 Liquid pharmaceutical compositions
12/26/2002	US20020198258 Therapeutic substances and methods of making and using same
12/26/2002	US20020198215 Terazosin transdermal device and methods
12/26/2002	US20020198192 A therapeutic formulation comprising a topically acceptable non-solid vehicle and carbamazepine for treating psoriasis skin disorder; gels, creams, ointments, lotions, liquids, and suspensions
12/26/2002	US20020198186 Dissolving the peptide in acetic acid to form a solution, mixing with water, and lyophilizing; treating female infertility and for gonad protection
12/26/2002	US20020198174 Disinfecting and solubilizing steroid compositions
12/26/2002	US20020198173 Viricides for treating HIV and hepatitis virus
12/26/2002	US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same
12/26/2002	US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence
12/26/2002	US20020198140 Administering zinc-free acylated insulin or analog via a pulmonary route; especially in powder form
12/26/2002	US20020198136 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc.
12/26/2002	US20020198135 Compositions for release of radiosensitizers, and methods of making and using the same
12/26/2002	US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/26/2002	US20020197598 Two hybrid assay that detects hiv-1 reverse transcriptase dimerization
12/26/2002	US20020197388 Method and apparatus for the coating of substrates for pharmaceutical use
12/26/2002	US20020197381 Caffeine complexes with enhanced taste, process for their preparation and their use
12/26/2002	US20020197337 Hypericum Perforatum L. Oleoresin, Procedure for Obtaining it and Uses of it
12/26/2002	US20020197336 Wound healing antiscarring topical composition of centella and ginseng
12/26/2002	US20020197333 DASC compositions, process for preparing same and suspensions containing same
12/26/2002	US20020197332 Treatment for ectoparasites
12/26/2002	US20020197328 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
12/26/2002	US20020197327 Taste masked pharmaceutical compositions
12/26/2002	US20020197325 Microparticles
12/26/2002	US20020197324 Delivery of drugs to mucosal surfaces
12/26/2002	US20020197323 Stable solid delivery system and method of preparing same
12/26/2002	US20020197322 Antimicrobial containing solventless hot melt adhesive composition
12/26/2002	US20020197321 Solid dispersing vaccine composition for oral delivery
12/26/2002	US20020197320 Composition and method for rectal delivery of a lincosamide antibiotic drug
12/26/2002	US20020197319 Method for coating pharmaceutical dosage forms
12/26/2002	US20020197318 Compositions
12/26/2002	US20020197317 Taste masking coating composition
12/26/2002	US20020197316 Dosage form comprising means for changing drug delivery shape
12/26/2002	US20020197315 Controlled release composite
12/26/2002	US20020197314 Anti-fungal composition
12/26/2002	US20020197313 Unit dosage forms for the treatment of herpes simplex
12/26/2002	US20020197312 Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
12/26/2002	US20020197311 Pharmaceutical preprations containing pyrogenic silicon dioxide
12/26/2002	US20020197310 Analgesics; solid dosage form
12/26/2002	US20020197309 Administering antidiabetic agent, glipizide
12/26/2002	US20020197308 Rapidly soluble drug composition

1 ... 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 ... 2991